Related Experiment Video
Updated: May 29, 2026
09:52
An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy
Published on: April 21, 2014
Glioblastoma. Part II: Future directions
Michael E Salacz1, Kenneth R Watson, David A Schomas
1Saint Luke's Brain Tumor Center, Kansas City, Mo, USA. msalacz@saint-lukes.org
Missouri Medicine
|September 13, 2011
Summary
Glioblastoma Multiforme (GBM) treatment has advanced, offering new hope. This review covers current GBM care standards and future research directions, including clinical trials and emerging technologies.
Area of Science:
- Neuro-oncology
- Clinical Medicine
- Medical Research
Background:
- Glioblastoma Multiforme (GBM) is a highly aggressive and feared primary malignant brain neoplasm.
- Despite its severity, recent therapeutic advancements have improved patient outcomes and clinical management.
- A comprehensive understanding of current and future GBM treatments is crucial for oncologists and patients.
Purpose of the Study:
- To review the multidisciplinary advances establishing the current standard of care for GBM management.
- To discuss ongoing research, including clinical trials and novel technologies, for future GBM therapies.
Main Methods:
- Evidence-based review of current GBM treatment protocols.
- Analysis of ongoing clinical trials and emerging technological advancements in neuro-oncology.
Main Results:
- Established multidisciplinary approaches form the current standard of care for GBM.
- Significant research efforts are underway, exploring new therapeutic avenues and technologies.
Conclusions:
- Recent advances in GBM treatment offer renewed hope for patients and clinicians.
- Ongoing research and technological innovation are paving the way for improved future GBM therapies.
